Kerry Wentworth, Chief Regulatory Officer at Flexion Therapeutics Inc (FLXN), sold 3,944 shares at $6.45 ($25K) on 2021-07-19, disclosed to the SEC on 2021-07-20.
Open-market sale of $25k FLXN by Chief Regulatory Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NUVB | SELL | 2026-04-08 | $904K | — | Filing → |
| NUVB | BUY | 2025-06-18 | $90K | — | Filing → |
| FLXN | SELL | 2021-01-07 | $152K | — | Filing → |